Health authorities are concerned about the dangers that three new generation anticoagulants, Eliquis, Pradaxa and Xarelo, could pose to public health. Appeared in 2008, these
News And Worlds
Health authorities are concerned about the dangers that three new generation anticoagulants, Eliquis, Pradaxa and Xarelo, could pose to public health. Appeared in 2008, these